Allergan CEO: More bold acquisitions are possible

Jim Cramer spoke to the CEO of Allergan fresh off its quarterly earnings. Did the stock deserve its beating, or is this an investing opportunity?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.